This often occurs alongside other gastrointestinal issues such as bloating, diarrhea, and vomiting
Additionally, Semaglutide GLP-1 injections are contraindicated in patients with a history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
GLP-1 medications carry black box warnings and potential side effects commonly including nausea, vomiting, diarrhea, constipation, and abdominal pain and require ongoing medical supervision
Yes, but transition planning with your provider is essential to prevent weight regain
Respecto a la funcin renal, la mayora de los agonistas GLP-1 no requieren ajuste de dosis en insuficiencia renal, aunque exenatide y lixisenatide tienen limitaciones en enfermedad renal crnica avanzada
It keeps injection volumes manageable across all dose levels